Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.75
+0.12 (1.57%)
At close: Aug 13, 2025, 4:00 PM
7.74
-0.01 (-0.13%)
After-hours: Aug 13, 2025, 4:04 PM EDT
Lifecore Biomedical Income Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | May '25 May 25, 2025 | May '24 May 26, 2024 | May '23 May 28, 2023 | May '22 May 29, 2022 | May '21 May 30, 2021 | 2016 - 2020 |
| Revenue | 128.87 | 128.26 | 103.27 | 111.27 | 100.87 | Upgrade
|
| Revenue Growth (YoY) | 0.47% | 24.20% | -7.19% | 10.31% | -36.98% | Upgrade
|
| Cost of Revenue | 88.57 | 86.41 | 75.28 | 72.2 | 61.94 | Upgrade
|
| Gross Profit | 40.3 | 41.85 | 27.99 | 39.07 | 38.94 | Upgrade
|
| Selling, General & Admin | 44.05 | 40.46 | 38.97 | 34.66 | 29.32 | Upgrade
|
| Research & Development | 8.26 | 8.58 | 8.74 | 7.84 | 6.68 | Upgrade
|
| Operating Expenses | 52.3 | 49.04 | 47.71 | 42.5 | 36.01 | Upgrade
|
| Operating Income | -12.01 | -7.19 | -19.72 | -3.43 | 2.93 | Upgrade
|
| Interest Expense | -21.84 | -18.09 | -17.58 | -15.47 | -8.93 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.41 | 36.45 | -0.81 | 6.57 | -10.97 | Upgrade
|
| EBT Excluding Unusual Items | -33.44 | 11.17 | -38.11 | -12.33 | -16.92 | Upgrade
|
| Merger & Restructuring Charges | 1.75 | -1.66 | -4.18 | -8.36 | -13.36 | Upgrade
|
| Gain (Loss) on Sale of Assets | -6.99 | - | 2.11 | - | - | Upgrade
|
| Other Unusual Items | - | - | -23.74 | - | -1.11 | Upgrade
|
| Pretax Income | -38.67 | 9.51 | -63.93 | -20.69 | -29.79 | Upgrade
|
| Income Tax Expense | 0.04 | 0.18 | 0.31 | -5.21 | -6.35 | Upgrade
|
| Earnings From Continuing Operations | -38.72 | 9.33 | -64.24 | -15.48 | -23.44 | Upgrade
|
| Earnings From Discontinued Operations | - | 2.68 | -35.33 | -101.24 | -8.86 | Upgrade
|
| Net Income to Company | -38.72 | 12.01 | -99.56 | -116.72 | -32.29 | Upgrade
|
| Net Income | -38.72 | 12.01 | -99.56 | -116.72 | -32.29 | Upgrade
|
| Preferred Dividends & Other Adjustments | 5.64 | - | - | - | - | Upgrade
|
| Net Income to Common | -44.36 | 12.01 | -99.56 | -116.72 | -32.29 | Upgrade
|
| Shares Outstanding (Basic) | 35 | 30 | 30 | 29 | 29 | Upgrade
|
| Shares Outstanding (Diluted) | 35 | 37 | 30 | 29 | 29 | Upgrade
|
| Shares Change (YoY) | -5.02% | 22.36% | 1.67% | 0.59% | 0.45% | Upgrade
|
| EPS (Basic) | -1.27 | 0.39 | -3.32 | -3.96 | -1.10 | Upgrade
|
| EPS (Diluted) | -1.27 | 0.33 | -3.32 | -3.97 | -1.10 | Upgrade
|
| Free Cash Flow | -13.62 | -18.14 | -38.92 | -52.53 | -8.75 | Upgrade
|
| Free Cash Flow Per Share | -0.39 | -0.49 | -1.30 | -1.78 | -0.30 | Upgrade
|
| Gross Margin | 31.27% | 32.63% | 27.10% | 35.11% | 38.60% | Upgrade
|
| Operating Margin | -9.32% | -5.60% | -19.10% | -3.08% | 2.91% | Upgrade
|
| Profit Margin | -34.42% | 9.37% | -96.41% | -104.89% | -32.01% | Upgrade
|
| Free Cash Flow Margin | -10.57% | -14.14% | -37.69% | -47.21% | -8.68% | Upgrade
|
| EBITDA | -3.98 | 0.77 | -7.04 | 14.23 | 8.13 | Upgrade
|
| EBITDA Margin | -3.09% | 0.60% | -6.82% | 12.79% | 8.06% | Upgrade
|
| D&A For EBITDA | 8.03 | 7.95 | 12.68 | 17.66 | 5.2 | Upgrade
|
| EBIT | -12.01 | -7.19 | -19.72 | -3.43 | 2.93 | Upgrade
|
| EBIT Margin | -9.32% | -5.60% | -19.10% | -3.08% | 2.91% | Upgrade
|
| Effective Tax Rate | - | 1.92% | - | - | - | Upgrade
|
| Revenue as Reported | 128.87 | 128.26 | 103.27 | 111.27 | - | Upgrade
|
| Advertising Expenses | - | - | 0.01 | 0.01 | 0 | Upgrade
|
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.